Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1981 1
1983 1
1984 1
1985 1
1986 1
1987 1
1990 1
1991 2
1992 4
1993 1
1994 1
1995 3
1997 2
1998 1
1999 1
2009 1
2015 1
2016 6
2017 8
2018 3
2019 3
2020 5
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Results by year
Filters applied: . Clear all
Page 1
Radioembolization-induced liver disease: a systematic review.
Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG. Braat MN, et al. Eur J Gastroenterol Hepatol. 2017 Feb;29(2):144-152. doi: 10.1097/MEG.0000000000000772. Eur J Gastroenterol Hepatol. 2017. PMID: 27926660 Review.
Hepatobiliary Imaging in Liver-directed Treatments.
van Roekel C, Reinders MTM, van der Velden S, Lam MGEH, Braat MNGJA. van Roekel C, et al. Among authors: braat mngja. Semin Nucl Med. 2019 May;49(3):227-236. doi: 10.1053/j.semnuclmed.2019.01.007. Epub 2019 Feb 20. Semin Nucl Med. 2019. PMID: 30954189 Review.
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study.
Braat AJAT, Bruijnen RCG, van Rooij R, Braat MNGJA, Wessels FJ, van Leeuwaarde RS, van Treijen MJC, de Herder WW, Hofland J, Tesselaar MET, de Jong HWAM, Lam MGEH. Braat AJAT, et al. Among authors: braat mngja. Lancet Oncol. 2020 Apr;21(4):561-570. doi: 10.1016/S1470-2045(20)30027-9. Epub 2020 Feb 26. Lancet Oncol. 2020. PMID: 32112737 Clinical Trial.
Personalized Dosimetry: The Way to Limit Hepatotoxicity.
Braat MNGJA, Braat AJAT, Lam MGEH. Braat MNGJA, et al. J Vasc Interv Radiol. 2020 Mar;31(3):515-516. doi: 10.1016/j.jvir.2019.11.038. Epub 2020 Jan 29. J Vasc Interv Radiol. 2020. PMID: 32007412 No abstract available.
Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study.
de Maar JS, Suelmann BBM, Braat MNGJA, van Diest PJ, Vaessen HHB, Witkamp AJ, Linn SC, Moonen CTW, van der Wall E, Deckers R. de Maar JS, et al. Among authors: braat mngja. BMJ Open. 2020 Nov 26;10(11):e040162. doi: 10.1136/bmjopen-2020-040162. BMJ Open. 2020. PMID: 33243800 Free PMC article. Clinical Trial.
48 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page